Evidence map›Paper›PMID 35763639›Full record

ReviewAsian Pacific journal of cancer prevention : APJCP2022

Using Intervention Mapping to Develop a Theory-Based Intervention to Promote Colorectal Cancer Screening in Egypt.

Ahmed Nawwar, Lori Brand Bateman, Somaia Khamess, Mona N Fouad, Waleed O Arafat, Salah-Eldin Abdelmonem, Sejong Bae, Laura Q Rogers, Barbara Hansen, Katie Falkner and 4 more

Abstract readReview
In one paragraph

Review in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ahmed NawwarAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.ORCID 0000-0002-7339-9134
Lori Brand BatemanUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.ORCID 0000-0003-4705-165X
Somaia KhamessAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.ORCID 0000-0003-0862-0004
Mona N FouadUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.ORCID 0000-0002-3522-4835
Waleed O ArafatAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.ORCID 0000-0002-6617-5992
Salah-Eldin AbdelmonemAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.ORCID 0000-0002-4373-5168
Sejong BaeUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.ORCID 0000-0001-9982-3223
Laura Q RogersUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.
Barbara HansenUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.ORCID 0000-0002-9046-3476
Katie FalknerUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.
Karim M AbdeltawabAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.
Eslam AboismailAlexandria Faculty of Medicine, Champollion St., Al Mesallah Sharq, Al Attarin, Alexandria, Egypt.
Amr El KholyUniversity of Alabama at Birmingham Heersink School of Medicine, Division of Preventive Medicine, 1717 11th Ave South, Birmingham, AL 35226, U.S.A.
Isabel ScarinciUniversity of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, 1824 6th Ave South, Birmingham, AL 35233 U.S.A.ORCID 0000-0003-2337-3021

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
NCI NIH HHS P30 CA013148
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) incidence and mortality rates are increasing in Egypt. Because no national screening guidelines exist, developing an effective evidence-based screening intervention could lower rates by early detection of pre-cancerous and cancerous lesions and polyps. This paper describes the development of a CRC screening intervention in Alexandria, Egypt using Intervention Mapping (IM). MATERIALS AND

methodsBetween September 2019 and March 2020, the successive steps of the IM process were completed. Beginning with the needs assessment, we conducted a literature review, held focus groups with residents of Alexandria, and conducted interviews with local gastroenterologists and oncologists. Program objectives and target audience were determined before designing the program components and implementation plan. Using the PRECEDE-PROCEED theoretical model, predisposing, reinforcing, and enabling screening barriers were assessed. Finally, we developed a Standard Operating Procedures manual detailing aspects of the intervention and evaluation to serve as a model for an expanded screening program.

resultsThe needs assessment, e.g., literature review, seven focus groups (N=61 participants) and interviews (N=17 participants), indicated that barriers among residents included CRC knowledge deficits, fear/anxiety regarding testing, high cost, and lack of accessibility. Physicians believed CRC testing should only be performed for high risk individuals. Findings from each step of the process informed successive steps. Our final intervention consisted of training components for medical students (Health Champions) who would deliver the intervention to patients in primary care waiting rooms, providing short descriptions of CRC risks and screening, educational brochures, and distributing vouchers for no-cost guaiac fecal occult blood test kits. Health Champions would then follow up with the patients, providing results and referrals for no-cost colonoscopy testing for those with abnormal results.

conclusionUtilizing the IM steps successfully led to development of a theory-based CRC screening intervention for Egypt. Next steps include the implementation of a feasibility pilot intervention.

Indexed as

Colorectal NeoplasmsOncologistsColonoscopyEarly Detection of CancerEgyptHumanscolorectal cancerFecal Occult Blood TestIntervention mappingLMIC healthscreening intervention

Identifiers

PMID35763639
PMCPMC9587817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.